{"product_id":"ucsf-cme-54th-annual-recent-advances-in-neurology-2021","title":"UCSF CME: 54th Annual Recent Advances in Neurology 2021","description":"\u003cdiv id=\"ucOverview_pnlOverview\"\u003e\n\u003ch4\u003eUCSF CME: 54th Annual Recent Advances in Neurology 2021\u003c\/h4\u003e\n\u003cbr\u003eThis meeting is designed for the practicing neurologist and provides a review of clinical neurology with emphasis on areas of recent advances and progress in patient management. Both current concepts and new advances in neurologic disorders will be covered.\u003cbr\u003e\u003cbr\u003e\u003ca href=\"https:\/\/www.ucsfcme.com\/2021\/MNR21001\/info.html#Top\"\u003e\u003cimg alt=\"Back To Top\" border=\"0\" class=\"lazyloaded\" data-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/top_arrow.gif?v=1770152528\" height=\"7\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/top_arrow.gif?v=1770152528\" width=\"33\"\u003e\u003c\/a\u003e\n\u003cbr\u003e\u003chr\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ucObjectives_pnlOverview\"\u003e\n\u003ca name=\"Objectives\"\u003e\u003c\/a\u003e\u003cspan id=\"ucObjectives_lblTitle\"\u003eObjectives:\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003eBased on discussions with UCSF faculty and practicing physicians at other institutions, the topics were chosen based on physician-identified need for practice-based knowledge. The purpose of this program is to increase attendee competence and improve clinical practice in neurology, specifically to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eApply new concepts to epilepsy, multiple sclerosis, aging and movement disorders in practice;\u003c\/li\u003e\n\u003cli\u003eRecognize and select headache, and dementia of stroke, and multiple sclerosis, headache, dementia, and apply best practices for their management.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ca href=\"https:\/\/www.ucsfcme.com\/2021\/MNR21001\/info.html#Top\"\u003e\u003cimg alt=\"Back To Top\" border=\"0\" class=\"lazyloaded\" data-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/top_arrow.gif?v=1770152528\" height=\"7\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/top_arrow.gif?v=1770152528\" width=\"33\"\u003e\u003c\/a\u003e\n\u003cbr\u003e\u003chr\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ucAccreditation_pnlOverview\"\u003e\n\u003ca name=\"Accreditation\"\u003e\u003c\/a\u003e\u003cspan id=\"ucAccreditation_lblTitle\"\u003eAccreditation:\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003eThe University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Educa tion to provide continuing medical education for physicians.\u003cbr\u003e\u003cbr\u003eUCSF designates this live activity for a maximum of 16.00 \u003cem\u003eAMA PRA Category 1 Credits\u003csup\u003eTM\u003c\/sup\u003e\u003c\/em\u003e. Physicians should claim only the credit commensurate with the extent of their participation in the activity.\u003cbr\u003e\u003cbr\u003eThis CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural and linguistic competency.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eGeriatric Medicine:\u003c\/strong\u003e The approved credits shown above include 2.75 credits toward meeting the requirement under California Assembly Bill 1820, Geriatric Medicine.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eNurses: \u003c\/strong\u003eFor the purpose of recertification, the American Nurses Credentialing Center accepts \u003cem\u003eAMA PRA Category 1 Credits\u003csup\u003eTM\u003c\/sup\u003e\u003c\/em\u003e issued by organizations accredited by the ACCME.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePhysician Assistants: \u003c\/strong\u003eAAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA. Category 1 CreditTM from organizations accredited by the ACCME.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePharmacy: \u003c\/strong\u003eThe California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for \u003cem\u003eAMA PRA Category 1 Credits\u003csup\u003eTM\u003c\/sup\u003e\u003c\/em\u003e.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePharmacotherapeutics CEUs for Nurses:\u003c\/strong\u003e For the purposes of recertification the American Nurses Credentialing Center accepts \u003cem\u003eAMA PRA Category 1 Credits\u003csup\u003eTM\u003c\/sup\u003e\u003c\/em\u003e issued by organizations accredited by the ACCME. This activity is designated for a maximum of 4.75 pharmacotherapeutic credits towards meeting the requirement for nursing pharmacology continuing education. Nurses should claim 0.1 CEUs for each contact hour of participation in designated pharmacotherapeutic continuing education.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePain Management and End-of-LifeCare: \u003c\/strong\u003eApproved credits include 1.00 toward meeting the requirement under California Assembly Bill 487, Pain Management and End-of-Life Care.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eABPN MOC Self-Assessment Credits\u003c\/strong\u003e\u003cbr\u003eThis year’s course features a post-test which is valid toward meeting the MOC Part II self-assessment requirements for the American Board of Psychiatry and Neurology. ABPN diplomates will receive Self-Assessment credits after passing the post-test.\u003cbr\u003e\u003cbr\u003e\u003ca href=\"https:\/\/www.ucsfcme.com\/2021\/MNR21001\/info.html#Top\"\u003e\u003cimg alt=\"Back To Top\" border=\"0\" class=\"ls-is-cached lazyloaded\" data-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/top_arrow.gif?v=1770152528\" height=\"7\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/top_arrow.gif?v=1770152528\" width=\"33\"\u003e\u003c\/a\u003e\n\u003cbr\u003e\u003chr\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ucCourseOutline_pnlOverview\"\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca name=\"CourseOutline\"\u003e\u003c\/a\u003e\u003cspan id=\"ucCourseOutline_lblTitle\"\u003eCourse Outline:\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eWEDNESDAY, FEBRUARY 10, 2021\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e12:00 pm Registration\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e1:00 Welcome and Introductions\u003cbr\u003eS. Andrew Josephson, MD\u003c\/li\u003e\n\u003cli\u003e1:10 G Movement Disorders: Advances in Management\u003cbr\u003eJill L. Ostrem, MD\u003cbr\u003eCaroline M. Tanner, MD, PhD\u003c\/li\u003e\n\u003cli\u003e2:05 Neuroinfectious Diseases Pearls\u003cbr\u003eKaren L. Roos, MD\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e2:50 Coffee Break\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e3:15 Rx The Future of Multiple Sclerosis Treatment\u003cbr\u003eStephen L. Hauser, MD\u003c\/li\u003e\n\u003cli\u003e3:50 Rx Multiple Sclerosis: Choosing Therapies to Improve Outcomes\u003cbr\u003eAri J. Green, MD, MCR\u003cbr\u003eJeffrey M. Gelfand, MD\u003cbr\u003eJoanne Guo, MD\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e5:00 Adjourn\u003c\/em\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eTHURSDAY, FEBRUARY 11, 2021\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e8:00 am Webinar Opens \/ Exhibit Hall Opens\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e8:30 Case Studies in Neuromusclar Disease: Diagnoses Not to Miss\u003cbr\u003eAnn N. Poncelet, MD\u003cbr\u003eMark A. Terrelonge, MD, MPH\u003c\/li\u003e\n\u003cli\u003e9:20 Rx Neurologic Pandemics of the Past, the Present, and Future: Polio, COVID-19, and AFM\u003cbr\u003eKaren L. Roos, MD\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e10:00 Coffee Break\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e10:20 PRx Difficult Headache Management Decisions\u003cbr\u003eMorris Levin, MD\u003c\/li\u003e\n\u003cli\u003e11:15 Neurorecovery: Concussion and Beyond\u003cbr\u003eCathra Halabi, MD\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e12:00 pm Lunch Break\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e2:00 G Epilepsy Advances: New Options for Old Problems\u003cbr\u003eSusannah C. Cornes, MD\u003cbr\u003eVikram R. Rao, MD, PhD\u003c\/li\u003e\n\u003cli\u003e2:50 Pediatric Neurology Pearls for the Adult Neurologist\u003cbr\u003eAudrey Foster-Barber, MD, PhD\u003c\/li\u003e\n\u003cli\u003e3:40 Rx Updates in Stroke 2021: New Evidence that Guides Clinical Practice\u003cbr\u003eWade S. Smith, MD, PhD\u003cbr\u003eClaude J. Hemphill III, MD, MAS\u003cbr\u003eS. Andrew Josephson, MD\u003cbr\u003eNerissa U. Ko, MD, MS\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e5:00 pm Adjourn\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFRIDAY, FEBRUARY 12, 2021\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e8:00 am Webinar Opens \/ Exhibit Hall Opens\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e8:30 An Interactive Session: Difficult Diagnosis\u003cbr\u003eJohn W. Engstrom, MD\u003cbr\u003eSarah R. Ahmad, MD\u003cbr\u003eMichael G. Erkkinen, MD\u003cbr\u003eSara C. LaHue, MD\u003cbr\u003ePaul J. Sampognaro, MD\u003cbr\u003eMelanie L. Stephens, PhD\u003c\/li\u003e\n\u003cli\u003eMaggie W. Waung, MD, PhD\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e10:20 Coffee Break\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e10:40 An Interactive Session: Difficult Diagnosis\u003cbr\u003e(continued)\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e12:00 pm Lunch Break\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e2:00 G Neurodegenerative Disorders: New Frontiers\u003cbr\u003eAimee W. Kao, MD, PhD\u003cbr\u003eBruce L. Miller, MD\u003c\/li\u003e\n\u003cli\u003e3:00 Common and Difficult Ethical Challenges in Neurology\u003cbr\u003eWinston Chiong, MD, PhD\u003c\/li\u003e\n\u003cli\u003e3:45 Clinical Problem Solving Exercise: Dueling Neurohospitalists\u003cbr\u003eVanja C. Douglas, MD\u003cbr\u003eElan L. Guterman, MD\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e5:00 pm Adjourn\/Evaluation\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003eG Geriatric Credit\u003cbr\u003eP Pain Credit\u003cbr\u003eRx Meets Requirements for Pharmacotherapeutics CEUs for NPs\/Nurses\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/www.ucsfcme.com\/2021\/MNR21001\/info.html#Top\"\u003e\u003cimg alt=\"Back To Top\" border=\"0\" class=\"ls-is-cached lazyloaded\" data-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/top_arrow.gif?v=1770152528\" height=\"7\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/top_arrow.gif?v=1770152528\" width=\"33\"\u003e\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ucChairs_pnlOverview\"\u003e\n\u003ca name=\"Chairs\"\u003e\u003c\/a\u003e\u003cspan id=\"ucChairs_lblTitle\"\u003eChairs:\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003eS. Andrew Josephson, MD\u003cbr\u003eCarmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist;\u003cbr\u003eDistinguished Professor and Chair, Department of Neurology\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954397057122,"sku":"MED-AMB02639","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/UCSF-CME-54th-Annual-Recent-Advances-in-Neurology-2021.jpg?v=1779375357","url":"https:\/\/meducourse.com\/products\/ucsf-cme-54th-annual-recent-advances-in-neurology-2021","provider":"Meducourse","version":"1.0","type":"link"}